Citius Pharmaceuticals Bolsa (NASDAQ: CTXR)

Últimas noticias sobre Citius Pharmaceuticals (NASDAQ:CTXR) Bolsa

Citius Pharma

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Advanced Environmental Recycling Technologies

AERT

AILE

CTXR

HONE

HSON

INTZ

KORE

LITM

NATR

PDYN

REKR

SLDP

VINC

WATT

Descubre los mayores ganadores y perdedores en el mercado previo tras movimientos impactantes en acciones clave hoy.

Las acciones de Vincerx Pharma (VINC) suben alrededor del 64%; 20 acciones que se mueven en premercado

News

Pre-Market Outlook

Markets

Trading Ideas

CCTG

LUNA

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: CVM, CCTG, LUNA, CTXR y GNS.

5 acciones en el foco este lunes: CVM, CCTG, LUNA, CTXR y GNS

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals Inc

<p>Clearwater Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) will release its quarterly earnings report on Tuesday, 2025-04-29. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Clearwater Paper to report an <strong>earnings per share</strong> (EPS) of $0.17.</p>
<p>Investors in Clearwater Paper are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Earnings Track Record</h3>
<p>Last quarter the company missed EPS by $0.84, which was followed by a 8.36% drop in the share price the next day.</p>
<p>Here's a look at Clearwater Paper's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.33</td>
<td>0.29</td>
<td>0.30</td>
<td>1.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-1.17</td>
<td>0.35</td>
<td>-0.53</td>
<td>1.43</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-8.0%</td>
<td>11.0%</td>
<td>-21.0%</td>
<td>11.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870503_0.png" alt="eps graph" /></p>
<h3>Market Performance of Clearwater Paper's Stock</h3>
<p>Shares of Clearwater Paper were trading at $24.42 as of April 25. Over the last 52-week period, shares are down 46.01%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analyst Views on Clearwater Paper</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Clearwater Paper.</p>
<p>A total of 1 analyst ratings have been received for Clearwater Paper, with the consensus rating being Outperform. The average one-year price target stands at $37.0, suggesting a potential 51.52% upside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of Mercer Intl, Magnera and Sylvamo, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Mercer Intl, with an average 1-year price target of $6.0, suggesting a potential 75.43% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Magnera, with an average 1-year price target of $24.0, suggesting a potential 1.72% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Sylvamo, with an average 1-year price target of $80.0, suggesting a potential 227.6% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Mercer Intl, Magnera and Sylvamo, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Clearwater Paper</td>
<td>Outperform</td>
<td>44.12%</td>
<td>$14.70M</td>
<td>26.21%</td>
</tr>
<tr>
<td>Mercer Intl</td>
<td>Neutral</td>
<td>3.81%</td>
<td>$76.18M</td>
<td>3.53%</td>
</tr>
<tr>
<td>Magnera</td>
<td>Outperform</td>
<td>119.11%</td>
<td>$71M</td>
<td>-9.14%</td>
</tr>
<tr>
<td>Sylvamo</td>
<td>Neutral</td>
<td>0.62%</td>
<td>$237M</td>
<td>9.08%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Clearwater Paper ranks at the top for Revenue Growth and Gross Profit among its peers. It is in the middle for Return on Equity.</p>
<h3>Get to Know Clearwater Paper Better</h3>
<p>Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.</p>
<h3>Understanding the Numbers: Clearwater Paper's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Clearwater Paper's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>44.12%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Clearwater Paper's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>51.43%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Clearwater Paper's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>26.21%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Clearwater Paper's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>9.55%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Clearwater Paper's debt-to-equity ratio is below the industry average at <strong>0.34</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/CLW/earnings"><strong>To track all earnings releases for Clearwater Paper visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

Preview: Clearwater Paper's Earnings

<p><strong>BrightSpire Capital</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRSP#NYSE">BRSP</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that BrightSpire Capital will report an <strong>earnings per share</strong> (EPS) of $0.17. </p>
<p>Anticipation surrounds BrightSpire Capital's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.00, leading to a 2.18% increase in the share price on the subsequent day.</p>
<p>Here's a look at BrightSpire Capital's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.18</td>
<td>0.19</td>
<td>0.22</td>
<td>0.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.18</td>
<td>0.21</td>
<td>0.22</td>
<td>0.23</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>18.0%</td>
<td>-8.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870492_0.png" alt="eps graph" /></p>
<h3>BrightSpire Capital Share Price Analysis</h3>
<p>Shares of BrightSpire Capital were trading at $4.77 as of April 25. Over the last 52-week period, shares are down 21.46%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/BRSP/earnings"><strong>To track all earnings releases for BrightSpire Capital visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


BRSP

Earnings Preview For BrightSpire Capital

Biotech

General

CTMX

CytomX Therapeutics Presents Preclinical Data For mRNA Encoded Masked IL-12 Molecule In Collaboration With Moderna

<p>American Assets Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAT#NYSE">AAT</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect American Assets Trust to report an <strong>earnings per share</strong> (EPS) of $0.53.</p>
<p>The announcement from American Assets Trust is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS beat by $0.05, leading to a 6.66% drop in the share price on the subsequent day.</p>
<p>Here's a look at American Assets Trust's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.50</td>
<td>0.54</td>
<td>0.54</td>
<td>0.67</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.55</td>
<td>0.71</td>
<td>0.60</td>
<td>0.71</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-7.000000000000001%</td>
<td>2.0%</td>
<td>3.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870483_0.png" alt="eps graph" /></p>
<h3>American Assets Trust Share Price Analysis</h3>
<p>Shares of American Assets Trust were trading at $18.68 as of April 25. Over the last 52-week period, shares are down 11.62%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Insights Shared by Analysts on American Assets Trust</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on American Assets Trust.</p>
<p>Analysts have given American Assets Trust a total of 2 ratings, with the consensus rating being Neutral. The average one-year price target is $21.0, indicating a potential 12.42% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of Alexander &amp; Baldwin, CTO Realty Growth and Global Net Lease, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Alexander &amp; Baldwin, with an average 1-year price target of $24.0, suggesting a potential 28.48% upside.</li>
<li>Analysts currently favor an Buy trajectory for CTO Realty Growth, with an average 1-year price target of $22.5, suggesting a potential 20.45% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Global Net Lease, with an average 1-year price target of $9.0, suggesting a potential 51.82% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Alexander &amp; Baldwin, CTO Realty Growth and Global Net Lease, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>American Assets Trust</td>
<td>Neutral</td>
<td>0.86%</td>
<td>$69.57M</td>
<td>0.76%</td>
</tr>
<tr>
<td>Alexander &amp; Baldwin</td>
<td>Outperform</td>
<td>18.18%</td>
<td>$25.79M</td>
<td>1.24%</td>
</tr>
<tr>
<td>CTO Realty Growth</td>
<td>Buy</td>
<td>19.60%</td>
<td>$26.59M</td>
<td>-2.83%</td>
</tr>
<tr>
<td>Global Net Lease</td>
<td>Outperform</td>
<td>-3.68%</td>
<td>$163.50M</td>
<td>-0.79%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>American Assets Trust ranks:<br />
- Top for Revenue Growth among peers.<br />
- Bottom for Gross Profit among peers.<br />
- Bottom for Return on Equity among peers.<br />
- Consensus rating is in the middle compared to peers.</p>
<h3>Discovering American Assets Trust: A Closer Look</h3>
<p>American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.</p>
<h3>Key Indicators: American Assets Trust's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> American Assets Trust's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>0.86%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> American Assets Trust's net margin is impressive, surpassing industry averages. With a net margin of <strong>7.91%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> American Assets Trust's ROE excels beyond industry benchmarks, reaching <strong>0.76%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> American Assets Trust's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.27%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.73</strong>.</p>
<p><a href="https://www.benzinga.com/quote/AAT/earnings"><strong>To track all earnings releases for American Assets Trust visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Insights Ahead: American Assets Trust's Quarterly Earnings

<p><strong>O-I Glass</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OI#NYSE">OI</a>) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that O-I Glass will report an <strong>earnings per share</strong> (EPS) of $0.24. </p>
<p>The market awaits O-I Glass's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Earnings Track Record</h3>
<p>During the last quarter, the company reported an EPS beat by $0.03, leading to a 2.81% increase in the share price on the subsequent day.</p>
<p>Here's a look at O-I Glass's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.08</td>
<td>0.04</td>
<td>0.44</td>
<td>0.39</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.05</td>
<td>-0.04</td>
<td>0.44</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>3.0%</td>
<td>-7.000000000000001%</td>
<td>15.0%</td>
<td>-16.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870474_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of O-I Glass were trading at $11.93 as of April 25. Over the last 52-week period, shares are down 19.82%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Views on O-I Glass</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on O-I Glass.</p>
<p>The consensus rating for O-I Glass is Buy, derived from 2 analyst ratings. An average one-year price target of $14.5 implies a potential 21.54% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>This comparison focuses on the analyst ratings and average 1-year price targets of  and O-I Glass, three major players in the industry, shedding light on their relative performance expectations and market positioning.</p>
<h3>Overview of Peer Analysis</h3>
<p>The peer analysis summary provides a snapshot of key metrics for  and O-I Glass, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>O-I Glass</td>
<td>Buy</td>
<td>-6.83%</td>
<td>$208M</td>
<td>-12.69%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>O-I Glass is at the bottom for Revenue Growth with a decrease of 6.83%. It is also at the bottom for Gross Profit at $208M. Additionally, it ranks lowest for Return on Equity at -12.69%. Overall, O-I Glass is positioned at the bottom compared to its peers across all metrics analyzed.</p>
<h3>Unveiling the Story Behind O-I Glass</h3>
<p>O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.</p>
<h3>Key Indicators: O-I Glass's Financial Health</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Challenges:</strong> O-I Glass's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-6.83%</strong>. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<p><strong>Net Margin:</strong> O-I Glass's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of <strong>-10.07%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> O-I Glass's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-12.69%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-1.71%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> O-I Glass's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>4.61</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<p><a href="https://www.benzinga.com/quote/OI/earnings"><strong>To track all earnings releases for O-I Glass visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: O-I Glass's Earnings Preview

<p>Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) reported quarterly earnings of $1.69 per share which beat the analyst consensus estimate of $1.46 by 15.75 percent. This is a 4.32 percent increase over earnings of $1.62 per share from the same period last year.  The company reported quarterly sales of $883.63 million which beat the analyst consensus estimate of $835.00 million by 5.82 percent.  This is a 5.78 percent increase over sales of $835.34 million the same period last year.</p>


Earnings Beats

Woodward Q2 Adj. EPS $1.69 Beats $1.46 Estimate, Sales $883.63M Beat $835.00M Estimate

<p>PJT Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect PJT Partners to report an <strong>earnings per share</strong> (EPS) of $1.01.</p>
<p>Investors in PJT Partners are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat EPS by $0.74, which was followed by a 1.81% increase in the share price the next day.</p>
<p>Here's a look at PJT Partners's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.16</td>
<td>0.91</td>
<td>0.69</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.90</td>
<td>0.93</td>
<td>1.19</td>
<td>0.98</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>2.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870461_0.png" alt="eps graph" /></p>
<h3>Market Performance of PJT Partners's Stock</h3>
<p>Shares of PJT Partners were trading at $134.67 as of April 25. Over the last 52-week period, shares are up 43.63%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Insights Shared by Analysts on PJT Partners</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on PJT Partners.</p>
<p>Analysts have provided PJT Partners with 1 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $177.0, suggesting a potential 31.43% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Virtu Finl, Lazard and Moelis, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for Virtu Finl, with an average 1-year price target of $38.33, suggesting a potential 71.54% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Lazard, with an average 1-year price target of $51.78, suggesting a potential 61.55% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Moelis, with an average 1-year price target of $70.6, suggesting a potential 47.58% downside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>The peer analysis summary presents essential metrics for Virtu Finl, Lazard and Moelis, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>PJT Partners</td>
<td>Neutral</td>
<td>45.27%</td>
<td>$151.26M</td>
<td>29.64%</td>
</tr>
<tr>
<td>Virtu Finl</td>
<td>Neutral</td>
<td>0.43%</td>
<td>$506.55M</td>
<td>7.08%</td>
</tr>
<tr>
<td>Lazard</td>
<td>Neutral</td>
<td>0.72%</td>
<td>$264.40M</td>
<td>13.35%</td>
</tr>
<tr>
<td>Moelis</td>
<td>Neutral</td>
<td>40.97%</td>
<td>$95.04M</td>
<td>10.86%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>PJT Partners ranks highest in Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.</p>
<h3>About PJT Partners</h3>
<p>PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.</p>
<h3>A Deep Dive into PJT Partners's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> PJT Partners displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>45.27%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> PJT Partners's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>10.75%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> PJT Partners's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>29.64%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>3.21%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> PJT Partners's debt-to-equity ratio is below the industry average. With a ratio of <b>1.9</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/PJT/earnings"><strong>To track all earnings releases for PJT Partners visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings Preview: PJT Partners

<p>During the last three months, 4 analysts shared their evaluations of Valvoline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVV#NYSE">VVV</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $42.0, a high estimate of $48.00, and a low estimate of $38.00. Highlighting a 0.78% decrease, the current average has fallen from the previous average price target of $42.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870456_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Valvoline. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm    &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;David Lantz         &#x7C;Wells Fargo         &#x7C;Lowers         &#x7C;Overweight     &#x7C;              $42.00&#x7C;$44.00              &#x7C;<br />
&#x7C;Max Rakhlenko       &#x7C;TD Securities       &#x7C;Announces      &#x7C;Buy            &#x7C;              $40.00&#x7C;-                   &#x7C;<br />
&#x7C;Jeffrey Zekauskas   &#x7C;JP Morgan           &#x7C;Raises         &#x7C;Neutral        &#x7C;              $38.00&#x7C;$37.00              &#x7C;<br />
&#x7C;Steven Shemesh      &#x7C;RBC Capital         &#x7C;Raises         &#x7C;Outperform     &#x7C;              $48.00&#x7C;$46.00              &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Valvoline. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Valvoline compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Valvoline's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Valvoline's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/VVV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Valvoline analyst ratings.</strong></a></p>
<h2>Get to Know Valvoline Better</h2>
<p>Valvoline Inc produces, markets, and sells automotive maintenance products, particularly lubricants, to retail outlets installers, and customers. The company offers various products such as engine oil, heavy-duty engine oil, motorcycle oil, grease and brake fluid, and others. Geographically, the majority of the revenue is generated from the United States of America.</p>
<h3>Valvoline's Financial Performance</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Valvoline's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>10.95%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Valvoline's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>22.11%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Valvoline's ROE excels beyond industry benchmarks, reaching <strong>44.1%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Valvoline's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>3.83%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>5.68</strong>, caution is advised due to increased financial risk.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

What Analysts Are Saying About Valvoline Stock

<p>Deep-pocketed investors have adopted a bullish approach towards Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in EXPE usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Expedia Group. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 54% leaning bullish and 36% bearish. Among these notable options, 7 are puts, totaling $1,019,126, and 4 are calls, amounting to $159,500.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $147.0 to $177.5 for Expedia Group over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Expedia Group's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Expedia Group's substantial trades, within a strike price spectrum from $147.0 to $177.5 over the preceding 30 days.</p>
<h3>Expedia Group Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870447_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>EXPE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/09/25</td>
<td>$19.85</td>
<td>$19.3</td>
<td>$19.37</td>
<td>$177.50</td>
<td>$595.2K</td>
<td align="right">0</td>
<td align="right">389</td>
</tr>
<tr>
<td>EXPE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/09/25</td>
<td>$19.85</td>
<td>$19.25</td>
<td>$19.3</td>
<td>$177.50</td>
<td>$110.1K</td>
<td align="right">0</td>
<td align="right">436</td>
</tr>
<tr>
<td>EXPE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/09/25</td>
<td>$5.15</td>
<td>$4.7</td>
<td>$5.11</td>
<td>$148.00</td>
<td>$101.9K</td>
<td align="right">3</td>
<td align="right">400</td>
</tr>
<tr>
<td>EXPE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/09/25</td>
<td>$4.9</td>
<td>$4.35</td>
<td>$4.77</td>
<td>$147.00</td>
<td>$95.3K</td>
<td align="right">0</td>
<td align="right">200</td>
</tr>
<tr>
<td>EXPE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/02/25</td>
<td>$1.8</td>
<td>$1.8</td>
<td>$1.8</td>
<td>$165.00</td>
<td>$54.0K</td>
<td align="right">145</td>
<td align="right">326</td>
</tr>
</tbody>
</table>
</p>
<h3>About Expedia Group</h3>
<p>Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.</p>
<p>After a thorough review of the options trading surrounding Expedia Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Current Position of Expedia Group</h3>
<ul>
<li>Trading volume stands at 957,457, with EXPE's price up by 0.54%, positioned at $160.98.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 10 days.</li>
</ul>
<h3>What The Experts Say On Expedia Group</h3>
<p>4 market experts have recently issued ratings for this stock, with a consensus target price of $159.25.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Expedia Group, which currently sits at a price target of $150.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Expedia Group, targeting a price of $174.<br />
&#x2A; An analyst from JP Morgan persists with their Neutral rating on Expedia Group, maintaining a target price of $170.<br />
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Expedia Group, maintaining a target price of $143. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Expedia Group options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

EXPE

Expedia Group Options Trading: A Deep Dive into Market Sentiment

<p>In the preceding three months, 11 analysts have released ratings for Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Deckers Outdoor, presenting an average target of $201.18, a high estimate of $284.00, and a low estimate of $100.00. Experiencing a 7.75% decline, the current average is now lower than the previous average price target of $218.09. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870446_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Deckers Outdoor among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm     &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;---------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Paul Lejuez         &#x7C;Citigroup            &#x7C;Lowers         &#x7C;Buy            &#x7C;             $150.00&#x7C;$215.00             &#x7C;<br />
&#x7C;Anna Andreeva       &#x7C;Piper Sandler        &#x7C;Lowers         &#x7C;Neutral        &#x7C;             $100.00&#x7C;$210.00             &#x7C;<br />
&#x7C;Jim Duffy           &#x7C;Stifel               &#x7C;Lowers         &#x7C;Hold           &#x7C;             $127.00&#x7C;$185.00             &#x7C;<br />
&#x7C;Paul Lejuez         &#x7C;Citigroup            &#x7C;Maintains      &#x7C;Buy            &#x7C;             $215.00&#x7C;$215.00             &#x7C;<br />
&#x7C;Jay Sole            &#x7C;UBS                  &#x7C;Raises         &#x7C;Buy            &#x7C;             $284.00&#x7C;$267.00             &#x7C;<br />
&#x7C;Jim Duffy           &#x7C;Stifel               &#x7C;Raises         &#x7C;Hold           &#x7C;             $185.00&#x7C;$181.00             &#x7C;<br />
&#x7C;Joseph Civello      &#x7C;Truist Securities    &#x7C;Lowers         &#x7C;Buy            &#x7C;             $225.00&#x7C;$235.00             &#x7C;<br />
&#x7C;Ike Boruchow        &#x7C;Wells Fargo          &#x7C;Lowers         &#x7C;Equal-Weight   &#x7C;             $210.00&#x7C;$215.00             &#x7C;<br />
&#x7C;Adrienne Yih        &#x7C;Barclays             &#x7C;Raises         &#x7C;Overweight     &#x7C;             $231.00&#x7C;$190.00             &#x7C;<br />
&#x7C;Tom Nikic           &#x7C;Needham              &#x7C;Maintains      &#x7C;Buy            &#x7C;             $246.00&#x7C;$246.00             &#x7C;<br />
&#x7C;Dana Telsey         &#x7C;Telsey Advisory Group&#x7C;Maintains      &#x7C;Outperform     &#x7C;             $240.00&#x7C;$240.00             &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Deckers Outdoor. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Deckers Outdoor compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Deckers Outdoor's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Capture valuable insights into Deckers Outdoor's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DECK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Deckers Outdoor analyst ratings.</strong></a></p>
<h2>Delving into Deckers Outdoor's Background</h2>
<p>Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2024, Ugg and Hoka accounted for 52% and 42% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships, but also operates e-commerce in more than 50 countries and about 178 company-operated stores. It generated 67% of its fiscal 2024 sales in the United States.</p>
<h3>A Deep Dive into Deckers Outdoor's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Deckers Outdoor showcased positive performance, achieving a revenue growth rate of <strong>17.1%</strong> as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>25.0%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Deckers Outdoor's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>18.82%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Deckers Outdoor's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>12.41%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Deckers Outdoor's debt-to-equity ratio is below the industry average. With a ratio of <b>0.1</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DECK

Demystifying Deckers Outdoor: Insights From 11 Analyst Reviews

<p>Deep-pocketed investors have adopted a bullish approach towards Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in COIN usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 134 extraordinary options activities for Coinbase Global. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 35% leaning bullish and 35% bearish. Among these notable options, 48 are puts, totaling $2,978,283, and 86 are calls, amounting to $10,109,020.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $2.5 to $450.0 for Coinbase Global during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of Coinbase Global stands at 1603.56, with a total volume reaching 38,481.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Coinbase Global, situated within the strike price corridor from $2.5 to $450.0, throughout the last 30 days.</p>
<h3>Coinbase Global Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870442_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$26.0</td>
<td>$24.25</td>
<td>$25.25</td>
<td>$450.00</td>
<td>$1.2M</td>
<td align="right">549</td>
<td align="right">500</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$196.95</td>
<td>$193.85</td>
<td>$195.37</td>
<td>$10.00</td>
<td>$195.3K</td>
<td align="right">135</td>
<td align="right">55</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$196.55</td>
<td>$193.6</td>
<td>$194.9</td>
<td>$10.00</td>
<td>$194.9K</td>
<td align="right">135</td>
<td align="right">65</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$195.15</td>
<td>$192.55</td>
<td>$193.88</td>
<td>$5.00</td>
<td>$193.8K</td>
<td align="right">713</td>
<td align="right">90</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$191.7</td>
<td>$188.55</td>
<td>$189.95</td>
<td>$10.00</td>
<td>$189.9K</td>
<td align="right">135</td>
<td align="right">21</td>
</tr>
</tbody>
</table>
</p>
<h3>About Coinbase Global</h3>
<p>Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States. The company intends to be the safe and regulation-compliant point of entry for retail investors and institutions into the cryptocurrency economy. Users can establish an account directly with the firm, instead of using an intermediary, and many choose to allow Coinbase to act as a custodian for their cryptocurrency, giving the company breadth beyond that of a traditional financial exchange. While the company still generates the majority of its revenue from transaction fees charged to its retail customers, Coinbase uses internal investment and acquisitions to expand into adjacent businesses, such as prime brokerage and data analytics.</p>
<p>Following our analysis of the options activities associated with Coinbase Global, we pivot to a closer look at the company's own performance.</p>
<h3>Coinbase Global's Current Market Status</h3>
<ul>
<li>Trading volume stands at 5,873,899, with COIN's price down by -2.63%, positioned at $204.13.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 10 days.</li>
</ul>
<h3>Expert Opinions on Coinbase Global</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $256.8.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Coinbase Global, maintaining a target price of $290.<br />
&#x2A; An analyst from JMP Securities persists with their Market Outperform rating on Coinbase Global, maintaining a target price of $400.<br />
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $245.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Coinbase Global with a target price of $169.<br />
&#x2A; An analyst from Compass Point has revised its rating downward to Sell, adjusting the price target to $180. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Coinbase Global options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


COIN

Looking At Coinbase Global's Recent Unusual Options Activity

<p>During the last three months, 5 analysts shared their evaluations of Bain Capital Specialty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCSF#NYSE">BCSF</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $17.6, a high estimate of $19.00, and a low estimate of $16.00. A decline of 1.12% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870438_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The perception of Bain Capital Specialty by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;     Analyst Firm      &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Finian O'Shea       &#x7C;Wells Fargo            &#x7C;Lowers         &#x7C;Overweight     &#x7C;              $16.00&#x7C;$19.00              &#x7C;<br />
&#x7C;Paul Johnson        &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers         &#x7C;Market Perform &#x7C;              $17.00&#x7C;$18.00              &#x7C;<br />
&#x7C;Paul Johnson        &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises         &#x7C;Market Perform &#x7C;              $18.00&#x7C;$17.00              &#x7C;<br />
&#x7C;Finian O'Shea       &#x7C;Wells Fargo            &#x7C;Raises         &#x7C;Overweight     &#x7C;              $19.00&#x7C;$18.00              &#x7C;<br />
&#x7C;Finian O'Shea       &#x7C;Wells Fargo            &#x7C;Raises         &#x7C;Overweight     &#x7C;              $18.00&#x7C;$17.00              &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bain Capital Specialty. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Bain Capital Specialty compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Bain Capital Specialty's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BCSF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Bain Capital Specialty analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>About Bain Capital Specialty</h2>
<p>Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.</p>
<h3>Understanding the Numbers: Bain Capital Specialty's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Bain Capital Specialty's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately <strong>-23.91%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Bain Capital Specialty's net margin is impressive, surpassing industry averages. With a net margin of <strong>81.64%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Bain Capital Specialty's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>1.94%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Bain Capital Specialty's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.86%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.22</strong>.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BCSF

5 Analysts Assess Bain Capital Specialty: What You Need To Know

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Exxon Mobil</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with XOM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 17 uncommon options trades for Exxon Mobil.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 64% bullish and 29%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $417,659, and 10 are calls, for a total amount of $641,708.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75.0 to $130.0 for Exxon Mobil over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Exxon Mobil's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Exxon Mobil's substantial trades, within a strike price spectrum from $75.0 to $130.0 over the preceding 30 days.</p>
<h3>Exxon Mobil 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870436_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/30/25</td>
<td>$1.83</td>
<td>$1.73</td>
<td>$1.73</td>
<td>$112.00</td>
<td>$206.3K</td>
<td>173</td>
<td align="right">0</td>
</tr>
<tr>
<td>XOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.85</td>
<td>$4.75</td>
<td>$4.85</td>
<td>$120.00</td>
<td>$142.1K</td>
<td>12.3K</td>
<td align="right">371</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.7</td>
<td>$4.6</td>
<td>$4.6</td>
<td>$95.00</td>
<td>$115.0K</td>
<td>5.7K</td>
<td align="right">258</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$7.9</td>
<td>$7.85</td>
<td>$7.85</td>
<td>$110.00</td>
<td>$73.0K</td>
<td>4.1K</td>
<td align="right">94</td>
</tr>
<tr>
<td>XOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.4</td>
<td>$3.3</td>
<td>$3.4</td>
<td>$105.00</td>
<td>$63.9K</td>
<td>13.2K</td>
<td align="right">408</td>
</tr>
</tbody>
</table>
</p>
<h3>About Exxon Mobil</h3>
<p>ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2023, it produced 2.4 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At the end of 2023, reserves were 16.9 billion barrels of oil equivalent, 66% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.5 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.</p>
<p>After a thorough review of the options trading surrounding Exxon Mobil, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Current Position of Exxon Mobil</h3>
<ul>
<li>Trading volume stands at 6,270,221, with XOM's price up by 0.05%, positioned at $108.62.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 4 days.</li>
</ul>
<h3>What The Experts Say On Exxon Mobil</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $128.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Mizuho persists with their Neutral rating on Exxon Mobil, maintaining a target price of $129.<br />
&#x2A; An analyst from UBS persists with their Buy rating on Exxon Mobil, maintaining a target price of $131.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Buy rating for Exxon Mobil, targeting a price of $135.<br />
&#x2A; An analyst from Scotiabank persists with their Sector Outperform rating on Exxon Mobil, maintaining a target price of $115.<br />
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Exxon Mobil with a target price of $130. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Exxon Mobil options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Check Out What Whales Are Doing With XOM

<p>In the latest quarter, 5 analysts provided ratings for G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $27.6, a high estimate of $32.00, and a low estimate of $21.00. A decline of 13.21% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870431_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>A comprehensive examination of how financial experts perceive G-III Apparel Group is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;    Analyst Firm     &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;---------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;Paul Kearney        &#x7C;Barclays             &#x7C;Lowers         &#x7C;Underweight    &#x7C;              $21.00&#x7C;$25.00              &#x7C;<br />
&#x7C;Dana Telsey         &#x7C;Telsey Advisory Group&#x7C;Maintains      &#x7C;Market Perform &#x7C;              $30.00&#x7C;$30.00              &#x7C;<br />
&#x7C;Paul Kearney        &#x7C;Barclays             &#x7C;Lowers         &#x7C;Underweight    &#x7C;              $25.00&#x7C;$29.00              &#x7C;<br />
&#x7C;Dana Telsey         &#x7C;Telsey Advisory Group&#x7C;Lowers         &#x7C;Market Perform &#x7C;              $30.00&#x7C;$38.00              &#x7C;<br />
&#x7C;Mauricio Serna      &#x7C;UBS                  &#x7C;Lowers         &#x7C;Neutral        &#x7C;              $32.00&#x7C;$37.00              &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to G-III Apparel Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of G-III Apparel Group compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for G-III Apparel Group's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into G-III Apparel Group's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/GIII/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on G-III Apparel Group analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Get to Know G-III Apparel Group Better</h2>
<p>G-III Apparel Group Ltd is a textile company. It makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. G-III has a substantial portfolio for licensed and proprietary brands, anchored by five global power brands: DKNY, Donna Karan, Calvin Klein, Tommy Hilfiger, and Karl Lagerfeld. The company has two reportable operations: Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, as well as sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenues from Wholesale operations.</p>
<h3>G-III Apparel Group: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, G-III Apparel Group showcased positive performance, achieving a revenue growth rate of <strong>9.77%</strong> as of 31 January, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>5.81%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> G-III Apparel Group's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.93%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> G-III Apparel Group's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.85%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> G-III Apparel Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.17</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


GIII

Where G-III Apparel Group Stands With Analysts

<p><strong>Medical Properties Trust's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPW#NYSE">MPW</a>) short percent of float has fallen 4.99% since its last report. The company recently reported that it has <strong>164.36 million shares sold short</strong>, which is 37.92% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 12.81 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Medical Properties Trust Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870429_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Medical Properties Trust has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Medical Properties Trust's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Medical Properties Trust's peer group average for short interest as a percentage of float is 4.63%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

What's Driving the Market Sentiment Around Medical Properties Trust?

<p>18 analysts have shared their evaluations of Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $256.5, a high estimate of $270.00, and a low estimate of $230.00. Surpassing the previous average price target of $252.11, the current average has increased by 1.74%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870424_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>A clear picture of Fiserv's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<p>&#x7C;      Analyst       &#x7C;     Analyst Firm      &#x7C; Action Taken  &#x7C;    Rating     &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C;<br />
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C;<br />
&#x7C;David Anderson      &#x7C;Barclays               &#x7C;Lowers         &#x7C;Overweight     &#x7C;             $230.00&#x7C;$265.00             &#x7C;<br />
&#x7C;James Friedman      &#x7C;Susquehanna            &#x7C;Lowers         &#x7C;Positive       &#x7C;             $240.00&#x7C;$250.00             &#x7C;<br />
&#x7C;Ole Slorer          &#x7C;Morgan Stanley         &#x7C;Raises         &#x7C;Overweight     &#x7C;             $268.00&#x7C;$267.00             &#x7C;<br />
&#x7C;Vasundhara Govil    &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers         &#x7C;Outperform     &#x7C;             $240.00&#x7C;$260.00             &#x7C;<br />
&#x7C;Timothy Chiodo      &#x7C;UBS                    &#x7C;Lowers         &#x7C;Buy            &#x7C;             $255.00&#x7C;$265.00             &#x7C;<br />
&#x7C;Ashwin Shirvaikar   &#x7C;Citigroup              &#x7C;Lowers         &#x7C;Buy            &#x7C;             $240.00&#x7C;$267.00             &#x7C;<br />
&#x7C;Rufus Hone          &#x7C;BMO Capital            &#x7C;Lowers         &#x7C;Outperform     &#x7C;             $232.00&#x7C;$254.00             &#x7C;<br />
&#x7C;James Friedman      &#x7C;Susquehanna            &#x7C;Lowers         &#x7C;Positive       &#x7C;             $250.00&#x7C;$270.00             &#x7C;<br />
&#x7C;Will Nance          &#x7C;Goldman Sachs          &#x7C;Raises         &#x7C;Buy            &#x7C;             $260.00&#x7C;$246.00             &#x7C;<br />
&#x7C;James Friedman      &#x7C;Susquehanna            &#x7C;Raises         &#x7C;Positive       &#x7C;             $270.00&#x7C;$230.00             &#x7C;<br />
&#x7C;David Anderson      &#x7C;Barclays               &#x7C;Raises         &#x7C;Overweight     &#x7C;             $265.00&#x7C;$235.00             &#x7C;<br />
&#x7C;Daniel Perlin       &#x7C;RBC Capital            &#x7C;Raises         &#x7C;Outperform     &#x7C;             $270.00&#x7C;$255.00             &#x7C;<br />
&#x7C;Vasundhara Govil    &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises         &#x7C;Outperform     &#x7C;             $260.00&#x7C;$238.00             &#x7C;<br />
&#x7C;Andrew Bauch        &#x7C;Wells Fargo            &#x7C;Raises         &#x7C;Overweight     &#x7C;             $270.00&#x7C;$240.00             &#x7C;<br />
&#x7C;Alex Markgraff      &#x7C;Keybanc                &#x7C;Raises         &#x7C;Overweight     &#x7C;             $270.00&#x7C;$250.00             &#x7C;<br />
&#x7C;Charles Nabhan      &#x7C;Stephens &amp; Co.         &#x7C;Raises         &#x7C;Overweight     &#x7C;             $270.00&#x7C;$255.00             &#x7C;<br />
&#x7C;Ole Slorer          &#x7C;Morgan Stanley         &#x7C;Raises         &#x7C;Overweight     &#x7C;             $267.00&#x7C;$258.00             &#x7C;<br />
&#x7C;Rufus Hone          &#x7C;BMO Capital            &#x7C;Raises         &#x7C;Outperform     &#x7C;             $260.00&#x7C;$233.00             &#x7C;</p>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Fiserv. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Fiserv compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for Fiserv's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Fiserv's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/FI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Fiserv analyst ratings.</strong></a></p>
<h2>Delving into Fiserv's Background</h2>
<p>Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.</p>
<h3>Fiserv's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.</p>
<p><strong>Decline in Revenue:</strong> Over the 3M period, Fiserv faced challenges, resulting in a decline of approximately <strong>-2.3%</strong> in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Fiserv's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>16.59%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>3.21%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Fiserv's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>1.08%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Fiserv's debt-to-equity ratio is below the industry average. With a ratio of <b>1.09</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Outlook: Fiserv Through The Eyes Of 18 Analysts

<p><strong>TD Synnex's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) short percent of float has risen 25.58% since its last report. The company recently reported that it has <strong>4.04 million shares sold short</strong>, which is 4.91% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.38 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>TD Synnex Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870423_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for TD Synnex has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing TD Synnex's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, TD Synnex's peer group average for short interest as a percentage of float is 6.25%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


What's Driving the Market Sentiment Around TD Synnex?

LZMH

LZ Technology Shares Halted On Circuit Breaker To The Downside Stock Now Down -2.62%

<p>Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) has outperformed the market over the past 5 years by 3.51% on an annualized basis producing an average annual return of 17.78%. Currently, Cboe Global Markets has a market capitalization of $22.31 billion. </p>
<p><strong>Buying $100 In CBOE:</strong> If an investor had bought $100 of CBOE stock 5 years ago, it would be worth <strong>$214.40</strong> today based on a price of $213.07 for CBOE at the time of writing.</p>
<h3>Cboe Global Markets's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1745870419_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


CBOE

Here's How Much $100 Invested In Cboe Global Markets 5 Years Ago Would Be Worth Today

<p>In the current market session, <strong>DexCom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>)</strong> share price is at $71.25, after a <strong>0.57%</strong> decrease. Over the past month, the stock spiked by <strong>5.85%</strong>, but over the past year, it actually fell by <strong>44.07%</strong>. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.</p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1745870418_0_0.png" alt="Past Year Chart" /></p>

<h3>How Does DexCom P/E Compare to Other Companies?</h3>
<p>The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. </p>
<p>DexCom has a lower P/E than the aggregate P/E of <strong>57.68</strong> of the Health Care Equipment &amp; Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1745870418_1.png" alt="Guage" /></p>

<p>In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes. </p>


Intraday Update

DXCM

A Look Into DexCom Inc's Price Over Earnings

Offerings

Press Releases

Citius Pharmaceuticals Announces Closing of $3 Million Registered Direct Offering

Stock Split

Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update

Small Cap

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Contracts

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock

CTOR

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Athira Pharma

Aytu BioPharma

Biofrontera

Cingulate

Cocrystal Pharma

Citius Pharmaceuticals

Evoke Pharma

Gelteq

Hoth Therapeutics

Impact BioMedical

Jaguar Health

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lipocine

Lyra Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

Talphera

Traws Pharma

TherapeuticsMD

D. Boral Capital

HC Wainwright & Co.

EF Hutton

Screenshot 2024-08-06 at 7.17.40 PM

TENK

Citius Pharmaceuticals To Receive 65 Million Shares Of TenX Keane For Merger Of Citius Oncology

Screenshot 2024-07-29 at 8.39.42 PM

From fighting cancer to treating bloodstream infections, Citius Pharmaceuticals Inc. (NASDAQ:CTXR) is busy trying to solve some of the world&#39;s ills. That&#39;s picking up steam with two of its lead products close to commercialization. 

Comments

Citius Pharmaceuticals

Noticias

Últimas noticias sobre Citius Pharmaceuticals (NASDAQ:CTXR) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL